Understanding Firm, Physician and Consumer Choice Behavior in the Pharmaceutical Industry
Marketing LettersPublished 1 December 2005
Puneet Manchanda, Dick R. Wittink, Andrew T. Ching, Paris Cleanthous, Min Ding, Xiaojing Dong
Citations66
SJR quartileQ1
SJR score2.04
SNIP1.23
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
Abstract
This paper argues that the pharmaceutical industry represents an exciting opportunity to carry out academic research. The nature of the industry allows researchers to answer new questions, develop new methodologies for answering these questions as well as to apply existing methodology to new data. The paper opens with some industry background, then provides a brief overview of some important research areas and discusses the open questions in each area. Issues of data type and availability are also discussed.
Keywords
Economics, Econometrics and FinancePharmacology, Toxicology and PharmaceuticsBusiness, Management and Accounting
American Journal of SociologySocial Contagion and Innovation: Cohesion versus Structural Equivalence
2,408 Citations1987Ronald S. Burt
American Journal of Sociology<i>Medical Innovation</i> Revisited: Social Contagion versus Marketing Effort
634 Citations2001Christophe Van den Bulte, Gary L. Lilien
Archives of Internal MedicineDrug-Related Morbidity and Mortality
612 Citations1995Jeffrey Johnson
The cost of drug-related morbidity and mortality in the ambulatory setting in the United States is considerable and should be considered in health policy decisions with regard to pharmaceutical benefits.
Management ScienceEndogeneity in Brand Choice Models
534 Citations1999J. Miguel Villas‐Boas, Russell S. Winer
American Journal of SociologySpatial and Temporal Heterogeneity in Diffusion
486 Citations1993David Strang, Nancy Brandon Tuma
EconometricaUncertainty and Learning in Pharmaceutical Demand
440 Citations2005Gregory S. Crawford, Matthew Shum
A dynamic matching model of demand under uncertainty in which patients learn from prescription experience about the effectiveness of alternative drugs is estimated, indicating that while there is substantial heterogeneity in drug efficacy across patients, learning enables patients and their doctors to dramatically reduce the costs of uncertainty in pharmaceutical markets.
New England Journal of MedicinePromotion of Prescription Drugs to Consumers
424 Citations2002Meredith B. Rosenthal, Ernst R. Berndt +3 more
Although the use of direct-to-consumer advertising has grown disproportionately to other forms of promotion, it continues to account for a small proportion of total promotional efforts and physicians must assist patients in evaluating health-related information obtained through direct advertising.
Journal of Marketing ResearchResponse Modeling with Nonrandom Marketing-Mix Variables
324 Citations2004Puneet Manchanda, Peter E. Rossi +1 more
The authors expand on the standard conditional model to include a model for the determination of the marketing-mix variables and find that physicians are not detailed optimally; high-volume Physicians are detailed to a greater extent than low-volume physicians without regard to responsiveness to detailing.
Marketing ScienceThe Role of Targeted Communication and Contagion in Product Adoption
315 Citations2008Puneet Manchanda, Ying Xie +1 more
The results from the Manhattan market indicate that both targeted communication and contagion have an effect on the individual physician's adoption decision, and it is found that marketing plays a large (relative) role in affecting early adoption.
Journal of Marketing ResearchTemporal Differences in the Role of Marketing Communication in New Product Categories
264 Citations2005Sridhar Narayanan, Puneet Manchanda +1 more
Journal of MarketingReturn on Investment Implications for Pharmaceutical Promotional Expenditures: The Role of Marketing-Mix Interactions
253 Citations2004Sridhar Narayanan, Ramarao Desiraju +1 more
The authors empirically explore the revenue impact of marketing-mix variables and their interactions and find pharmaceutical direct-to-consumer advertising and detailing affect demand synergistically, detailing raises price elasticity, and detailing has a higher return on investment than does direct- to- consumer advertising.
Management ScienceDynamic Portfolio Selection of NPD Programs Using Marginal Returns
230 Citations2002Christoph H. Loch, Stylianos Kavadias
A dynamic model of resource allocation is developed, taking into account multiple interacting factors, such as independent or correlated, uncertain market payoffs that change over time, increasing or decreasing returns from the NPD investment, carry-over of the investment benefit over multiple periods, and interactions across market segments.
Management ScienceAre Physicians “Easy Marks”? Quantifying the Effects of Detailing and Sampling on New Prescriptions
204 Citations2004Natalie Mizik, Robert Jacobson
It is found that detailing and free drug samples have positive and statistically significant effects on the number of new prescriptions issued by a physician, however, the magnitudes of the effects are modest.
The Journal of Economic PerspectivesPharmaceuticals in U.S. Health Care: Determinants of Quantity and Price
172 Citations2002Ernst R. Berndt
The U.S. pharmaceutical industry has again become the focus of considerable controversy, and distinctions between short, medium and long-run costs are critical, as is that between economic and accounting costs.
Journal of Economics & Management StrategyDo Pharmaceutical Sales Respond to Scientific Evidence?
164 Citations2002Pierre Azoulay
It is concluded that product-market competition in the pharmaceutical industry is shaped by both advertising rivalries and scientific rivalries, and that drug advertising may perform an important informative function.
Archives of Internal MedicineTreatment Options in Knee Osteoarthritis
160 Citations2004Liana Fraenkel, Sidney T. Bogardus +2 more
The patient treatment preferences derived in this study conflict with the current widespread use of nonselective NSAIDs in older patients with arthritis.
Management ScienceStructuring the New Product Development Pipeline
156 Citations2002Ming Ding, Jehoshua Eliashberg
A normative model for structuring pipelines for new product development NPD situations, which suggests that firms tend to use narrower pipelines for their new drug development than they should, and thereby they underspend on research and development.
Journal of Economics & Management Strategy<scp>The Effect of Prescription Drug Advertising on Doctor Visits</scp>
146 Citations2005Toshiaki Iizuka, Ginger Zhe Jin
Marketing ScienceAnalysis of New Product Diffusion Using a Four-Segment Trial-Repeat Model
145 Citations1994Minhi Hahn, Se-Hoon Park +2 more
Journal of Marketing ResearchDirect-to-Consumer Advertising and Drug Therapy Compliance
141 Citations2005Marta Wosińska
The author finds that the impact is small in economic terms, the impact spills over to other brands, and, in certain cases, the effect may decrease average compliance rates.
PubMedThe effects and role of direct-to-physician marketing in the pharmaceutical industry: an integrative review.
136 Citations2005Puneet Manchanda, Elisabeth Honka
The pharmaceutical industry plays a vital role in the world's economy, as well as in ensuring the welfare of its citizens, and spends more money on marketing than on research and development.
Forum for Health Economics & PolicyDemand Effects of Recent Changes in Prescription Drug Promotion
134 Citations2003Meredith B. Rosenthal, Ernst R. Berndt +3 more
It is estimated that 13 to 22 percent of the recent growth in prescription drug spending is attributable to the effects of DTCA, and the findings suggest that, for these classes of drugs, D TCA has been effective primarily through increasing the size of the entire class.
Marketing LettersResponsiveness of Physician Prescription Behavior to Salesforce Effort: An Individual Level Analysis
131 Citations2004Puneet Manchanda, Pradeep K. Chintagunta
It is found that while detailing has positive impact on prescriptions written, there are diminishing returns to detailing for most physicians in the authors' sample, and the results are used to show how detailing reallocation can increase revenues.
Journal of EconometricsAn empirical model of learning and patient spillovers in new drug entry
128 Citations2003Andrea Coscelli, Matthew Shum
A diffusion model is specified and estimated based on a Bayesian learning process whereby doctors update their beliefs about omeprazole’s quality relative to existing drugs after observing its effects on the patients that have been prescribed this drug.
Journal of Marketing ResearchDeterminants of Product-Use Compliance Behavior
101 Citations2004Douglas Bowman, Carrie M. Heilman +1 more
International Journal of Research in MarketingDiffusion of new pharmaceutical drugs in developing and developed nations
97 Citations2004Ramarao Desiraju, Harikesh S. Nair +1 more
SSRN Electronic JournalHeterogeneous Learning and the Targeting of Marketing Communication for New Products
90 Citations2007Sridhar Narayanan, Puneet Manchanda
Marketing ScienceStrategic Pricing and Detailing Behavior in International Markets
89 Citations2005Pradeep K. Chintagunta, Ramarao Desiraju
SSRN Electronic JournalResponse Modeling with Non-random Marketing Mix Variables
88 Citations2003Puneet Manchanda, Peter E. Rossi +1 more
This work expands on the standard conditional model to include a model for the determination of the marketing mix variables and finds that physicians are not detailed optimally; high volume physicians are detailed to a greater extent than low volume physicians without regard to responsiveness to detailing.
SSRN Electronic JournalJust What the Patient Ordered? Direct-to-Consumer Advertising and the Demand for Pharmaceutical Products
88 Citations2002Marta Wosińska
Empirical analysis of patient-level prescription claims reveals that direct-to-consumer advertising does impact the choice probability but there are two caveats.
Journal of Marketing ResearchQuantifying the Benefits of Individual-Level Targeting in the Presence of Firm Strategic Behavior
84 Citations2009Xiaojing Dong, Puneet Manchanda +1 more
A pharmaceutical firm's decision on the allocation of detailing visits across individual physicians is studied, and it is suggested that accounting for firm strategic behavior improves profitability by 14%–23% compared with segment-level targeting.
International Journal of Industrial OrganizationConsumer learning and heterogeneity: Dynamics of demand for prescription drugs after patent expiration
66 Citations2010Andrew T. Ching
Evidence is found that the brand-name price elasticities of demand are often less than one and increase over time, suggesting that brand- name firms might set their prices lower than what they would do if they were myopic, in order to slow down the learning process for generic qualities.
Social Science & MedicineUsing the health belief model to predict initial drug therapy defaulting
36 Citations1985Jack E. Fincham, Albert I. Wertheimer
The results indicate the utility of the HBM as a tool of prediction for this form of noncompliance, and suggest possible other patient behaviors that may be able to be predicted by the model.
Quantitative Marketing and EconomicsThe effects of detailing on prescribing decisions under quality uncertainty
34 Citations2010Andrew T. Ching, Masakazu Ishihara
It is argued that the results point out the importance of developing a structural model that captures the mechanism of how detailing/advertising conveys information in the market under study.
Health AffairsGeneric Dispensing And Substitution In Mail And Retail Pharmacies
21 Citations2004Marta Wosińska, Robert S. Huckman
This work states that mail-order pharmacies have lower aggregate generic-dispensing rates than their retail counterparts, and an alternative measure--one that fully controls for differences in price and indications across molecules within a category--eliminates the discrepancy in dispensing rates.
Elements of Pharmaceutical Pricing
20 Citations1997E Kolassa
This book discusses the role of price in the decision to Purchase, Prescribe, or Use Pharmaceuticals, and the value of a Pharmaceutical Product at the Change of Millennia.
Roi Implications for Pharmaceutical Promotional Expenditures: The Role of Marketing Mix Interactions
12 Citations2004Sridhar Narayanan, Ramarao Desiraju +1 more
Using data from a category of pharmaceutical products, the study empirically explores the impact of interactions between pairs of marketing mix elements on ROI and finds interesting variations on how these interactions affect revenues.
